Tenax Therapeutics to present Phase 3 LEVEL results at ESC Congress 2026
AI Summary- Tenax Therapeutics announced a presentation of Phase 3 LEVEL results.
- The presentation is scheduled for ESC Congress 2026.
- The results will appear in late-breaking scientific sessions.